Australian Border Force: Illegal tobacco and vaping products worth A$1 billion in tax revenue gap intercepted in Q2 2025

Feb.05
Australian Border Force: Illegal tobacco and vaping products worth A$1 billion in tax revenue gap intercepted in Q2 2025
Australian Border Force intercepts over $1 billion worth of illegal tobacco and e-cigarettes, totaling 467+ tons. Leading enforcement against smuggling.

Key Points

  • Total Value: In the second quarter of the 2025/26 financial year (1 October to 31 December 2025), the tax evasion associated with illicit tobacco and e-cigarettes intercepted at Australia's borders amounted to approximately A$1 billion (approximately US$680 million).
    Weight: Over 467 tonnes of illicit cigarettes and loose tobacco were seized.
  • New South Wales: 14.4 million cigarettes seized from a Chinese shipping container in October; 2.5 tonnes of molasses tobacco (concealed behind "fruit juice") seized days later; 52,800 e-cigarettes seized from a Kuala Lumpur-bound container in November, declared as "dumbbells" and "trampolines".
  • Rise in e-cigarette liquid smuggling: 3 litres seized from Hong Kong air freight in Adelaide (declared as aroma diffusers); over 5.5 litres seized from multiple parcels originating UK and France via Brisbane international mail.
  • Victoria Airport: Multiple passenger smuggling cases in recent months originating from Lebanon and Taiwan; one case involving a female passenger arriving from Lebanon is pending prosecution.

 


 

2Firsts, Feb 5, 2026

 

According to the Australian Border Force (ABF), illicit tobacco and vapes linked to an estimated A$1 billion in evaded duty were stopped at the Australian border in Q2 of FY2025/26 (Oct 1–Dec 31, 2025), including seizures totaling more than 467 tonnes of illicit cigarettes and loose-leaf tobacco. Using the rate A$1 = US$0.68, the evaded duty figure is approximately US$680 million.

 

ABF said sea cargo interceptions featured prominently. In New South Wales, Australia, officers seized over 14.4 million cigarettes in mid-October from a shipping container originating from China. Days later, they found more than 2.5 tonnes of molasses tobacco concealed behind “juice” consignments. In November, ABF discovered 52,800 vapes in a container from Kuala Lumpur, Malaysia, which had been declared as “dumbbells and trampolines.”

 

ABF also flagged a rise in vape liquid detections. In Adelaide, Australia, officers seized three litres from air cargo originating in Hong Kong, declared as diffuser fragrance. In Brisbane, Australia, officers intercepted multiple international mail consignments from the UK and France, totaling more than 5.5 litres.

 

In Tasmania, Australia, ABF reported one of its largest cigarette seizures just before Christmas, after officers searched a container from Poland and uncovered more than 5.4 million illicit cigarettes, falsely declared as stretch film.

 

At Melbourne Airport in Victoria, Australia, ABF detected multiple traveler-smuggling attempts over the past three months, including:

 

  • a male traveler and companion arriving from Lebanon with 7kg of tobacco;
  • a male traveler from Taiwan with 23,400 cigarettes concealed in luggage;
  • a female traveler from Lebanon carrying 11.5kg of tobacco and 13,200 cigarettes (pending prosecution);
  • two male travelers from Lebanon with over 5,000 cigarettes and 11.75kg of tobacco.

 

Illicit Tobacco and Vape Enforcement Commander Greg Dowse said the figures underscore that illicit tobacco remains a top ABF priority, adding that ABF targets the black-market business model before goods reach Australia and continues post-border through cooperation and intelligence sharing. ABF encouraged anyone with information to contact Border Watch.

 

Image source: Australian Border Force (ABF)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Vape Manufacturer Ispire Expands Malaysia Operations, Negotiates Southeast Asia OEM Deal as Nicotine Pouch and US Age-Gating Businesses Develop
Vape Manufacturer Ispire Expands Malaysia Operations, Negotiates Southeast Asia OEM Deal as Nicotine Pouch and US Age-Gating Businesses Develop
US-listed vaping technology and manufacturing company Ispire Technology reported fiscal first-quarter 2027 revenue of $27.5 million on November 9, 2026, down 9.3% year over year but up 3.2% sequentially. Gross margin recovered to 16.2%, while its net loss widened to $6.4 million from $3.3 million a year earlier. Management attributed the sales decline primarily to tighter European vaping regulation and reduced distributor orders. Ispire is expanding manufacturing in Malaysia and negotiating an OEM/ODM agreement with a Southeast Asian vaping brand, with an announcement anticipated in January 2027. The company estimates that Malaysian manufacturing offers an approximately 25% US tariff advantage over China-based production. However, it continues to purchase products from Shenzhen Yi Jia Technology Co., Ltd., a manufacturer controlled by its chairman, and reported $52 million in non-current related-party payables at September 30.
company
Nov.11 by 2Firsts Perspectives
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09